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ABSTRACT
Cis-natural antisense transcripts (cis-NATs) are long noncoding RNAs transcribed from the opposite strand
and overlapping coding and noncoding genes on the sense strand. cis-NATs are widely present in the
human genome and can be involved in multiple mechanisms of gene regulation. Here, we describe the
presence of cis-NATs in the 30 distal region of the c-MYC locus and investigate their impact on
transcriptional regulation of this key oncogene in human cancers. We found that cis-NATs are produced as
consequence of the activation of cryptic transcription initiation sites in the 30 distal region downstream of
the c-MYC 30UTR. The process is tightly regulated and leads to the formation of two main transcripts,
NAT6531 and NAT6558, which differ in their ability to fold into stem-loop secondary structures. NAT6531
acts as a substrate for DICER and as a source of small RNAs capable of modulating c-MYC transcription. This
complex system, based on the interplay between cis-NATs and NAT-derived small RNAs, may represent an
important layer of epigenetic regulation of the expression of c-MYC and other genes in human cells.
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Introduction
Cis-natural antisense transcripts (cis-NATs) are long noncod-
ing RNAs transcribed from the opposite strand totally or par-
tially overlapping annotated protein-coding or non-protein-
coding genes.1,2 NATs are widespread in eukaryotic genomes
with about 40 to 70% of human and mouse genes having
NATs.3,4 NATs have been implicated in multiple regulatory
mechanisms, including RNA masking,5,6 alternative splicing,7
genomic imprinting,8 chromatin remodeling9 and RNA edit-
ing.10 Cis-NATs have been classiﬁed on the basis of their orien-
tation relative to the associated gene as head-to-head (50 to 50),
tail-to-tail (30 to 30) or fully overlapping.11 Sense-antisense tran-
script pairs are co-expressed or inversely correlated more fre-
quently than expected by chance, indicating interdependence
between the two transcriptional units.11 High conservation and
coupling of sense-antisense expression are more frequent for
the tail-to-tail NAT-gene pairs. The function of many of the
identiﬁed NATs is still unknown and novel mechanisms under-
lying the functional interaction between overlapping NAT-gene
pairs are emerging. For instance, TALAM1, a recently identi-
ﬁed cis-NAT to the human lncRNA MALAT1, interacts with
the sense transcript in cis and regulates the 3' cleavage, process-
ing and nuclear accumulation of MALAT1.12
Sense-antisense overlapping transcripts are also processed by
DICER or DICER-like proteins to produce small interfering
RNAs (siRNAs).13 This phenomenon has been extensively investi-
gated inA. thalianawhere cis-NAT-derived siRNAs (nat-siRNAs)
are formed in response to speciﬁc stimuli and interfere with the
sense transcript of the NAT-gene pair.14 A genome-wide analysis
of cis-NAT expression in A. thaliana has identiﬁed many siRNAs
enriched in the overlapping region of NAT-gene pairs and sug-
gests that NAT-siRNAs may be involved in silencing of the gene
transcript.14,15 In S. pombe, primary endogenous siRNA (endo-
siRNAs) are generated by overlapping sense-antisense transcripts
in a DICER-dependentmanner.16 The biogenesis of endo-siRNAs
is controlled at multiple levels, underlying the importance of these
regulatory mechanisms.16 Endo-siRNAs derived from naturally
occurring double stranded RNAs aremuch rarer in somatic mam-
malian cells. Endo-siRNAs are present in higher amounts in
mouse oocytes.17,18 However, only few other examples have been
reported, including murine testis, kidney19 and brain.20 Endo-siR-
NAs have been found in human embryonic kidney cells, but their
production in differentiated human cells is still controversial.5,21
Cis-NATs can overlap promoters, introns, exons, enhancers
and untranslated regions of the corresponding genes.1,22
Cis-NATs are generally produced at much lower levels than the
overlapping gene transcripts and their expression is controlled
by structured and regulated transcription initiation sites similar
to the gene promoters. Promoters of transcribed cis-NATs pres-
ent RNA polymerase 2 (RNAPol2) binding and active chroma-
tin marks, such as histone H3 acetylation at K27 and K9
(H3K9Ac and H3K27Ac).23 Conversely, promoters of silent
cis-NATs have low H3K9Ac and H3K27Ac and are associated
with repressive histone marks. Histone deacetylases (HDACs)
remove acetyl groups from histones and deplete activation
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marks from chromatin.24 Interestingly, HDACs are also found
associated with promoters and gene bodies of actively tran-
scribed genes.24 During transcription, HDACs are thought to
take part in cycles of deposition and removal of acetyl group on
histones and to facilitate transcriptional initiation and elonga-
tion.24-26 Paradoxically, treatment with HDACs inhibitors
represses transcription of many active genes.24-26 Furthermore,
a tight control over cis-NATs transcription is also required to
avoid interference with overlapping and surrounding genes on
the opposite strand and this might involve histone modiﬁca-
tions catalyzed by HDACs and histone acetyltransferases
(HATs). In ﬁssion yeast the HDAC Clr6 prevents antisense
transcription and has a protective function suppressing anti-
sense cryptic initiation sites, suggesting that HDACs might
exert similar functions in mammalian cells.27
In this study, we investigated the presence and function of cis-
NATs in the c-MYC locus. c-MYC is an oncogene activated in
several human cancers.28 We identiﬁed cis-NATs overlapping
the c-MYC gene and extending downstream the 30-untraslated
region (30UTR). We show that cis-NATs in the 30 distal region
respond to changes in the chromatin status within the c-MYC
locus and are involved in ﬁne tuning the transcription of the gene.
Materials and methods
Cell lines, small interfering RNA transfection and drug
treatment
Human cell lines and culturing conditions have been described
previously.29,30 The siGL3 Negative Control siRNA29 and
DICER siRNA were purchased from Ambion. Cells were trans-
fected with siRNAs using Interferin (Polyplus). Small RNAs
generated by in vitro DICER reaction were transfected in PC3
cells using Lipofectamine (Invitrogen). Cells were treated with
Trichostatin A (TSA, Alexis Biochemicals), SAHA (suberanilo-
hydroxamic acid, Cayman Chemical) or DMSO (Sigma).
RNA extraction
Total RNA was obtained from cell lines by phenol:chloroform
extraction. RNA samples were treated with DNase I (Qiagen)
and then precipitated with sodium acetate (Sigma). To examine
intracellular distribution of the transcripts cells were lysed in
100 mM Tris HCl (pH 7.4), 100 mM NaCl, 2.5 mM MgCl2,
40 mg/ml digitonin (RSB-100).31 After centrifugation the super-
natant containing cytosolic RNA was collected. Pellets were
suspended in RSB-100 with 0.5% Triton X (RSB-100T) and
after centrifugation the supernatant containing nuclear RNA
was recovered. The ﬁnal pellets were suspended in RSB-100T,
sonicated and centrifuged. The supernatant containing chro-
matin-bound RNA was recovered. RNA was extracted from all
the collected fractions using TriReagent (Invitrogen).
Reverse transcriptase polymerase chain reaction (RT-PCR)
RT-PCR was performed using Verso 1 Step kit Thermostart
(ThermoScientiﬁc). Samples were analyzed by agarose gel elec-
trophoresis followed by staining with GelRed (Biotium) and
digital imaging with aImager (Innotech) with indicated
primers (Supplementary Table 1). For strand-speciﬁc RT-PCR
only the forward primers were added to the reverse transcrip-
tase reaction to amplify antisense strand selectively. Experi-
ments were repeated two or more times to ensure
reproducibility and representative images are shown. Optimal
conditions for each primer set (e.g., amount of starting RNA
and PCR ampliﬁcation cycles) were determined in preliminary
experiments. To detect c-MYC and Actin mRNA by RT-PCR
total RNA (50 ng) was subjected to 22 and 20 cycles of ampliﬁ-
cation, respectively. To detect NATs by strand-speciﬁc RT-
PCR 100 ng of total RNA, following directional RT, were sub-
jected to 30 cycles of PCR ampliﬁcation. These conditions
ensured linear ampliﬁcation of the target RNAs and therefore a
semi-quantitative assessment of their amounts. Negative (i.e.,
no RNA; no RT step) and positive (i.e., genomic DNA) control
reactions were performed to determine the speciﬁcity of the
produced amplicons and the absence of genomic contaminants.
50 Rapid ampliﬁcation of cDNA ends (50RACE)
50 RACE was performed with gene-speciﬁc primers for anti-
sense transcripts (Supplementary Table 1) using 50 RACE Sys-
tem (Invitrogen) and RNA from PC3 cells treated with SAHA
(2.5 and 10 mM) or DMSO. cDNA was puriﬁed, tailed with
dCTP and ampliﬁed consecutively with gene speciﬁc primers
and either Abridged Anchor primer or Abridged Universal
Ampliﬁcation primer provided in the 50RACE system kit. Final
PCR products were cloned into pGEM-T Easy vector
(Promega) and sequenced.
Immunoblotting
Cells were lysed in 0.5% SDS, 0.5% NP40, 140 mM NaCl and
10 mM Tris-HCl, pH 7.5. Gel electrophoresis and immunoblot-
ting were done as already described.29 Immunoblots were
developed using antibodies directed to c-MYC (BD Bioscien-
ces), b-tubulin (Santa Cruz), acetylated histone H3 (H3Ac)
(Millipore).
Chromatin immunoprecipitation (ChIP)
Cells were cross-linked with formaldehyde and processed as
described.29 Antibodies toward acetyL-Histone H3 and RNA
polymerase 2 (RNAPol2) (Millipore)29 were used for immuno-
precipitation. Quantitative real time PCR (qPCR) was per-
formed using SYBR Green FAST qPCR (KAPA Biosystem) on
an ABI Step One Plus (Applied Biosystems). The amount of
input and immunoprecipitated DNA was calculated in refer-
ence to standard curves. Data are presented as fraction of
immunoprecipitated DNA relative to input DNA.
In vitro transcription
Templates for in vitro transcription were prepared from 200 ng
of genomic DNA ampliﬁed by Pwo SuperYield DNA Polymer-
ase (Roche) with primers Myc C5866 Fw and T7prom-Myc
C6558 Rev, containing also T7 promoter sequence, for NAT
6558; with primers Myc C5906 Fw and T7 prom-Myc C6531
Rev, for NAT6531 (Supplementary Table 1). PCR products were
RNA BIOLOGY 1743
then puriﬁed and in vitro transcribed by T7 RNA Polymerase
from Escherichia coli BL 21/pAR 1219 (Roche) for 15 min at
37C. DNA was digested by DNAse I at 37C for 15 min and
RNA cleaned by LiCl Precipitation Solution (7.5 M) (Thermo
Scientiﬁc). Production of the correct transcripts was veriﬁed by
denaturating polyacrylamide gel electrophoresis.
DICER cleavage assay
In vitro transcribed NAT6531 or NAT6558 (3 mg) were heat-
denatured at 95C for 1 min and immediately chilled on ice for
5 min. Transcripts were folded in 25% glycerol, 0.05% Triton-
X, 1 mM MgCl2, 50 mM NaCl, 30 mM TrisHCl (pH 6.8) for
15 min at 25C. An aliquot of the reaction was suspended in
denaturing loading 2X buffer (TBE 2X, 61.6% formamide,
2.4 M urea) and kept as denatured RNA control size. Folded
RNA (1 mg) was digested for 2 h at 37C with Turbo DICER
(AMS Biotechnology) according to the manufacturer’s instruc-
tions. A second aliquot of folded RNA was incubated in parallel
in absence of the enzyme, as control for nonspeciﬁc fragmenta-
tion. Denatured, folded and diced NAT6531 and NAT6558
were loaded on native 2% agarose TAE gel and run 10V/cm.
Small and long RNA fractions (cut off 200 nt) from DICER
cleavage reaction were also isolated using mirVanaTM miRNA
Isolation Kit (Ambion), following the manufacturer’s instruc-
tions, and used for small RNAs cloning, Northern blot analysis
and cell transfection.
Isolation and cloning of small RNAs derived from DICER
cleaved NAT6531
Small RNAs derived from DICER digestion of NAT6531 were
puriﬁed by mirVanaTM miRNA Isolation Kit (Ambion) and
cloned using miRCAT Small RNA Cloning Kit (Integrated
DNA Technologies) according to the manufacturer’s protocol.
A total of 18 clones were sequenced.
Northern blotting
DICER digestion products of in vitro transcribed NAT6531 and
NAT6558 (50 ng) were suspended in denaturing loading 2X
buffer, loaded on 5% or 12% denaturing Urea PAGE, trans-
ferred to nylon membranes, positively charged (Roche) and
cross-linked by EDC for 2 h at 60C.32 Northern blotting to
detect long transcripts or small RNAs was performed using
Digoxigenin NHS Ester (DIG) LNA probe 6333 or 6083 (Exi-
qon), respectively.33,34 Signal detection was obtained by DIG
Nucleic Acid Detection Kit (Roche). For speciﬁc detection of
endogenous antisense transcripts, DIG-labeled RNA probes
covering the full-length NATs and internally labeled with
digoxigenin-UTP were synthesized from PCR templates by T7
RNA polymerase according to the DIG RNA labeling kit proto-
col (Roche). Brieﬂy, 10–12 mg of RNA samples extracted from
cells transfected for 72 h with siGL3 or siDICER (100 nM) and
then treated with SAHA or DMSO for additional 6 h were
diluted in denaturing loading 2X buffer. RNA was separated on
12% or 15% denaturing Urea-PAGE, transferred to nylon
membranes and cross-linked by UV. Membranes were incu-
bated overnight with DIG labeled RNA probes.
GRO-Seq and RNA-Seq data analysis
Raw data from global nuclear run-on sequencing (GRO-Seq)
performed in various cell lines were downloaded. Sources of
the data are reported in Supplementary Table 2. For each data
set, raw reads in fastq ﬁles were extracted, quality controlled
and aligned with bowtie2 (version 2.2.1)35 allowing up to 1 mis-
match and accepting uniquely mapping reads on the reference
genome GRCh37.p13 provided by Genecode. Samtools (version
0.1.19)36 was used to convert sam to bam ﬁles and sort them.
Using HOMER (Hypergeometric Optimization of Motif
EnRichment) suite of tools for Motif Discovery and next-gener-
ation sequencing analysis,37 we predicted genome-wide all the
transcription events in each data set (“ﬁndPeaks.pl”) allowing
the minimum size of 50 bp for transcript body detection. Only
the transcripts that were not classiﬁed as isoforms of annotated
genes were selected. Alignments of paired-ends, stranded
RNA-Seq reads data were obtained from the platform http://
genome.crg.es/encode_RNA_dashboard/hg19 for Hela and
K562 cells. Samples with polyA-enriched cytosolic RNA and
polyA-enriched and polyA-depleted nuclear RNA were consid-
ered for the analysis. Regions of interest were selected and
indexed with samtools. To visualize GRO-seq and RNA-seq
data Integrative Genomics Viewer (IGV) was used (version
2.3.32). Alignment of the RNA-seq raw reads was obtained for
each panel inspecting mapped reads in the format of sorted,
indexed bam ﬁles directly uploaded into the IGV visualization
tool. This allows to display windows of read alignments in bam
ﬁles and to show the distribution of mapped reads within the
region of interest (each window) in the individual samples.
The analysis of reads distribution does not take into account
the corresponding library size or the total number of mapped
reads as normalization of raw reads is not required for intra-
sample comparison.
RNA secondary structure prediction and sequence
analysis software
Mfold, a RNA structure prediction tool based on the energy
minimization model,38 was used to examine the folding and sec-
ondary structural elements in NAT6531 and NAT6558.
Sequence search was performed using BLAST (Basic Local
Alignment Search Tool, https://blast.ncbi.nlm.nih.gov/Blast.cgi).
To search for potential microRNA-like binding sites in the
c-MYC locus we used StarMiR,39 a web server tool within the
Sfold suite that identiﬁes sites based on feature similarities with
experimentally deﬁned miRNA binding events. The entire
coding sequence (CDS) of c-MYC and 2 kb in the 50 (pro-
moter-50UTR) and 30 (30UTR) region were examined.
Results
Antisense transcription in the c-MYC locus
We searched for evidence of antisense transcription overlap-
ping the c-MYC gene using strand-speciﬁc RT-PCR (ssRT-
PCR) with primer sets spanning different segments of the locus
from the 50UTR to the region downstream the 30UTR
(Fig. 1A). RNA was isolated from PC3 cells, a prostate cancer
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cell line with high c-MYC expression. Antisense transcripts
were detected in the region overlapping the 50UTR, exon1,
exon 2, 30UTR and up to »2 kb downstream the 30UTR
(30distal region). The antisense transcripts were present prefer-
entially in the nuclear and chromatin fraction with the 30UTR
and 30distal transcripts almost exclusively associated to the
chromatin (Fig. 1B). As control of the fractionation procedure,
mature c-MYC mRNA was found in the cytoplasm and nuclei.
We observed also an antisense transcript comprising sequences
of both exon1 and exon2, due to the splicing of the intervening
intron 1 (Fig. 1A). The spliced exon1/exon2 antisense tran-
script was more abundant in the soluble nuclear than in the
chromatin-bound fraction, suggesting that the transcript was
released from chromatin after splicing (Fig. 1B).
To support our ﬁndings, we interrogated public RNA-Seq
data sets in the Encode performed in various cell types (http://
genome.crg.es/encode/). We inspected stranded RNA-Seq data
from polyadenylated (polyA)-enriched and polyA-depleted
RNA extracted from the cytosolic and nuclear fractions of
HeLa cells (Fig. 1C) and K562 cells (Supplementary Fig. 1A).
PolyA-depleted nuclear RNA is enriched of unstable transcripts
that are retained in the nucleus or on the chromatin and do not
undergo maturation and export to the cytoplasm.40 In line with
our data, we found evidence of antisense transcription overlap-
ping the c-MYC locus. Speciﬁcally, antisense transcripts were
seen in the 30distal region downstream the 30UTR in the
polyA-depleted nuclear fraction (Fig. 1C, top panel). Antisense
transcripts covering the exon1-exon2 region were present both
Figure 1. Antisense transcription in the c-MYC locus. (A) Map of the c-MYC locus and position of the detected antisense transcripts (red boxes). (B) Expression and intracel-
lular distribution of antisense transcripts overlapping and downstream the c-MYC gene in PC3 cells determined by strand-speciﬁc RT-PCR. (C) Distribution of antisense
reads overlapping the c-MYC gene detected by RNA-Seq in polyA-depleted (top) and polyA-enriched (middle) nuclear RNA and polyA-enriched cytosolic RNA (bottom) in
HeLa cells. Gray boxes, 30distal NATs.
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in the polyA-depleted and polyA-enriched nuclear fraction
(Fig. 1C, top and middle panel). Conversely, antisense tran-
scripts in the 30distal region of the c-MYC locus were relatively
less in the polyA-enriched cytosolic fraction (Fig. 1C, lower
panel), in line with limited maturation and export to the cyto-
plasm of these transcripts. These data suggested that the pres-
ence of cis-NATs in the c-MYC locus is a common
phenomenon. To further support this point, we examined addi-
tional prostate cancer cell lines for evidence of antisense tran-
scription in the 30 distal region of the gene using ssRT-PCR
(Supplementary Fig. 1B). Transcripts in antisense orientation
were detected, although with different levels, in all the 5 human
cell lines examined.
Antisense transcripts in the c-MYC locus are controlled
by the local histone H3 acetylation level
Antisense transcription may be controlled by local histone acet-
ylation and deacetylation.27 Accordingly, we examined the
changes in distribution of acetylated histone H3 (H3Ac), a
mark of transcriptionally active chromatin, within the c-MYC
locus after treatment with the pan-HDAC inhibitor suberanilo-
hydroxamic acid (SAHA). A 6 h treatment with SAHA
increased global H3Ac in a dose-dependent manner, indicating
effective inhibition of histone deacetylation (Fig. 2A). At the
level of the c-MYC locus, H3Ac was high at the TSS while lower
or barely detectable at the 30UTR and the distal downstream
region of the gene in control cells (Fig. 2B). SAHA (10 mM) sig-
niﬁcantly reduced H3Ac at the c-MYC TSS, despite the dose-
dependent increase in global H3Ac. Notably, SAHA selectively
increased H3Ac at the 30UTR and even more at the 30 distal
downstream region (4-fold increase). This redistribution of
chromatin marks was also reﬂected in changes in RNAPol2
binding at the c-MYC TSS and in 30 distal region (Supplemen-
tary Fig. 2A). Interestingly, RNAPol2 occupancy increased at
the low dose of SAHA (2.5 mM) both at the TSS and at the
30distal region.
To assess how the changes in H3Ac impacted locally on the
transcriptional activity across the c-MYC locus, we examined
c-MYC mRNA and antisense transcripts after treatment with
SAHA. c-MYC mRNA and the antisense transcripts overlap-
ping exon1/intron1 and the 30UTR increased slightly at the
lower dose (2.5 mM), whereas they decreased at the higher dose
(10 mM), indicating a dose-dependent response to SAHA
(Fig. 2C). Conversely, the 30 distal antisense transcripts
increased considerably with both doses of SAHA, reﬂecting the
Figure 2. Histone H3 acetylation and antisense transcription in the c-MYC locus. (A) Global histone H3 acetylation (H3Ac) determined by Western blotting in PC3 cells
untreated (control, Co) or treated with vehicle only (0) or SAHA (2.5–10 mM) for 6 h. Tubulin was used as loading control. (B) Acetylated histone H3 in the c-MYC locus
determined by chromatin immunoprecipitation in PC3 cells treated with vehicle (DMSO) or SAHA (2.5–10 mM) for 6 h. Data are normalized to input. (C) c-MYC mRNA and
antisense transcript expression determined by strand-speciﬁc RT-PCR in PC3 cells treated with vehicle (DMSO) or SAHA (2.5–10 mM) for 6 h. Actin mRNA is used as control
gene. (D) c-MYC mRNA level determined by RT-PCR in PC3 cells treated with 2.5 (left) and 10 (right) mM SAHA for 2–8 h. (E) c-MYC mRNA expression determined by RT-
PCR in PC3 cells treated with vehicle (DMSO), SAHA or TSA for 24 h. (F) c-MYC protein level determined by Western blotting in PC3 cells untreated (Control) or treated
with vehicle (DMSO), SAHA (10mM) or TSA (300 nM) for 24 h.
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local increase of H3Ac. The concomitant changes in histone
marks, RNAPol2 binding and c-MYC mRNA suggest that
SAHA likely affects c-MYC transcription via activation or
repression of transcriptional initiation and elongation.
A time-course experiment conﬁrmed the biphasic response
of c-MYC mRNA to the low dose of SAHA (Fig. 2D). A slight
increase of c-MYC mRNA was seen at early times (4–6 h) fol-
lowed by a decrease at later times (8 h) in cells treated with
2.5 mM SAHA. Conversely, treatment with 10 mM SAHA con-
sistently decreased c-MYC mRNA within 2–8 h. Furthermore,
c-MYC mRNA (Fig. 2E) and protein (Fig. 2F) were consistently
reduced after 24 h of treatment with the HDAC inhibitors
SAHA (10 mM) and trichostatin (TSA, 300 nM). Thus, inhibi-
tion of HDACs represses c-MYC transcription concomitantly
with a change in antisense transcription and histone H3 acety-
lation in the 30 distal region of the gene, leading to the hypothe-
sis that antisense transcripts generated in this region might
intervene in c-MYC transcriptional repression.
Cryptic antisense initiation sites are activated by HDAC
inhibition in the 30distal region
We performed 50RACE to identify the 50ends and possible tran-
scription initiation sites of the antisense transcripts in the
30UTR and the 30distal region. RNA was extracted from cells
untreated or treated with 2.5 and 10 mM SAHA. After the
50RACE the products were separated by gel electrophoresis,
puriﬁed and sequenced. In untreated cells a single transcript
was detected with a putative initiation site at position C6531
with respect to the c-MYC TSS corresponding to about 1.3 kb
downstream the 30UTR (Fig. 3A, lane 1). Surprisingly, rather
than increasing the level of this transcript, SAHA induced the
appearance of alternative transcripts. In cells incubated with
2.5 and 10 mM SAHA we found 2 antisense transcripts with
putative initiation sites at positions C6558 and C7281, respec-
tively (Fig. 3A, lane 2 and 3).
We observed a similar phenomenon with the appearance of
diverse antisense initiation sites activated upon SAHA treat-
ment in the region overlapping the c-MYC 30UTR (Fig. 3B). In
untreated cells we did not detect any antisense transcript in this
region (Fig. 3B, lane 1). However, after treatment with 2.5 mM
SAHA 2 main 50RACE products, corresponding to antisense
transcripts putatively starting at the positions C5636 and
C5865, respectively, were found (Fig. 3B, lane 2). At 10 mM of
SAHA a different pattern was observed with a ﬁrst antisense
transcript starting at position C5462 and a second one at posi-
tion C5905 (Fig. 3B, lane 3). These results indicated that chro-
matin remodeling consequent to gradual HDAC inhibition
results in broad and complex changes in antisense transcription
across the c-MYC locus with induction of different transcripts
at the low and high dose of SAHA. Fig. 3C shows a summary of
the putative initiation sites and antisense transcripts identiﬁed
by 50RACE in the region overlapping and downstream the c-
MYC 30UTR. Using a primer (C6083) that excluded the most
abundant transcripts seen by 50RACE in this region, we
detected low level transcripts extending only few hundred bases
further downstream from the 30UTR (Supplementary Fig. 3).
Interestingly, no ampliﬁcation products were obtained by
50RACE using a more distal primer (C6379). These ﬁndings
indicate that the antisense transcripts detected in the 30UTR
and in the more 30 distal region derive from distinct transcrip-
tional units, whose boundary resides between position C6083
and C6379.
To estimate the extension of the antisense transcripts initi-
ated at each of the sites found downstream the 30UTR, we per-
formed directional ssRT-PCR with primer sets that partially
discriminated between the various transcripts (Fig. 3D). In line
with the 50RACE results, we detected the transcript starting at
C6531 (primer set C6379/C6519) in untreated cells (Fig. 3D).
In cells treated with SAHA the alternative initiation sites at
positionC6558 (2.5 mM) and C7281 (10 mM) generated longer
transcripts detected with the more distal primer sets (C6379/
C6553 and C6837/C7086) and overlapping the transcript initi-
ated at position C6531 (NAT6531) in control cells.
To estimate also the extension of the transcripts in the
30direction, we performed ssRT-PCR with primers (C5866,
C5906 and C6060) positioned at increasing distance from the
putative initiation sites at C6531 and C6558 (Fig. 3E). In cells
treated with SAHA the detected transcripts that extended up to
the position the most downstream primer, C5866 (Fig. 3E).
Therefore, the NATs induced in presence of by SAHA
(NAT6538 and NAT7281) were longer and extended further
toward the c-MYC 30UTR than in untreated cells.
To have additional evidence of the antisense transcripts
identiﬁed in the 30 region of the c-MYC locus we interrogated
global nuclear run-on sequencing (GRO-Seq) data sets.
GRO-Seq has the advantage of detecting nascent transcripts
independently of stability, polyadenylation and intra-cellular
localization and therefore has greater probability to identify
low abundance unstable transcripts.41 Consulting the in-house
built compendium of GRO-Seq data sets from multiple cell
types we found antisense transcripts in the 30UTR and 30 distal
region overlapping those experimentally identiﬁed by ssRT-
PCR and 50RACE in PC3 cells, thus conﬁrming and extending
our observations (Fig. 3F).
We performed also an analysis of the effects of SAHA on
transcription in the c-MYC locus in immortalized normal pros-
tate epithelial cells.30 Normal prostate epithelial cells have lower
basal level of c-MYC mRNA compared with prostate cancer
PC3 cells.29 SAHA, both at 2.5 and 10 mM, reduced c-MYC
level (Supplementary Fig. 4). This was associated with reduced
production of antisense transcripts in the 30 distal region in
SAHA-treated epithelial cells, unlike the induction seen in PC3
cells. Thus, the dynamic relation between mRNA and antisense
transcription in the c-MYC locus may differ substantially
between cancer and normal epithelial cells, although further
studies are clearly needed.
NAT6531 is processed by DICER into small RNAs
Our data indicate the presence of two close antisense tran-
scripts, NAT6531 and NAT6558, along with a more distal one,
NAT7281, in control and SAHA treated PC3 cells. NAT6531
and NAT6558 differ only for few extra bases at 50 and 30 ends
in the longer transcript. Using the RNA structure prediction
algorithm Mfold38 we examined the possibility that this differ-
ence in the sequence and length could translate into differential
folding and formation of distinct secondary structures of the
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Figure 3. Mapping antisense transcripts in the 30 distal region of the c-MYC gene. (A-B) Analysis of products generated by 50RACE starting from position C6083 (A) and
position C4772 (exon 3) (B). RNA was isolated from control (1) and SAHA treated PC3 cells (2, 3). M, marker (C) Position of the antisense transcripts and of primers used
for 50RACE experiments in A and B. (D-E) Expression and extension of antisense transcripts by strand-speciﬁc RT-PCR (top panels) and schematic representation of tran-
script initiation sites and PCR primer positions (bottom panels). (F) Predictions of antisense transcripts in the 30 distal region based on GRO-Seq data from multiple cell
lines. Numbers indicate the 50ends of the antisense transcripts found by 50RACE in PC3 cells.
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NATs. RNA secondary structure is an important determinant
of the function of noncoding RNAs deﬁning recognition sites
for RNA binding proteins, microRNA binding, RNA modiﬁca-
tions and processing.42-44 We found overall a high similarity in
the predicted folding of NAT6531 and NAT6558 (Fig. 4A).
However, there were small local differences, particularly evi-
dent at the level of a short stem-loop present in NAT6531 and
absent in NAT6558.
Short stem-loops can be recognized by RNA processing
enzymes such as DICER and may represent sites for generation
of small RNAs.45-47 We hypothesized that the short stem-loop
in NAT6531 could serve as substrate for DICER cleavage and
consequently be the precursor of small RNAs. To test this
hypothesis, we transcribed NAT6531 and NAT6558 in vitro
and, after folding, incubated them with human recombinant
DICER. The products of the reactions were examined by aga-
rose gel electrophoresis (Fig. 4B). In line with our hypothesis,
NAT6531 was processed by DICER in vitro to produce a dis-
tinct population of short RNAs. After incubation with DICER
we observed a decrease of the full length transcript and the
appearance of RNA products of the size expected for DICER-
processed small RNAs (»20 nt in length) (Fig. 4B, lane 3).
Notably, incubation of NAT6558 with DICER did not lead to
accumulation of similar small RNA products (Fig. 4B, lane 6).
To conﬁrm detection of the small RNAs generated from
NAT6531 by DICER and determine the origin, DICER reaction
products were run on denaturating polyacrylamide gels, blotted
and hybridized with probes corresponding to different regions
of NAT6531 and NAT6558. The LNA probe LNA6333 hybrid-
izes to a portion common to both NAT6531 and NAT6558,
while the LNA probe LNA6083 recognizes the sequence within
the predicted stem-loop in NAT6531 (Fig. 4A). The third probe
(RNA 5866–6558) corresponds to the full length NAT6558
sequence. Northern blots performed after in vitro DICER
Figure 4. Differential folding and cleavage by DICER of 30 distal antisense transcripts in the c-MYC locus. (A) Predicted secondary structure of NAT6531 (top) and NAT6558
(bottom) using Mfold. Left, close-up of the stem-loop structure present in NAT6531 and missing in NAT6558. Position of short LNA probes 6083 (light gray) and 6333 (dark
gray) relative to the folded NATs is shown. (B) Cleavage of in vitro transcribed NAT6531 (lanes 1–3) and NAT6558 (lanes 4–6) by DICER. Samples contained NATs either
denaturated (lanes 1 and 4), refolded (lanes 2 and 5) or refolded and incubated with DICER (lane 3 and 6). White boxes, region of small RNA DICER products. (C) Northern
blot analysis of NAT6531 and NAT6558 in vitro transcribed and incubated with DICER. Electrophoresis was run on 5% (left panel) or 12% (middle and right panels) poly-
acrylamide gels. Blots were hybridized with probes LNA 6333, LNA 6083 and RNA 5866–6558. Light gray arrow, full length transcripts; dark gray arrows, DICER-processed
small RNAs.
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digestion showed the decrease of full length NAT6531 detected
by LNA6333 (Fig. 4C). Small RNA products were recognized in
NAT6531 containing reactions by LNA6083 and the full length
(5866–6558) RNA probe, conﬁrming that NAT6531 was proc-
essed by DICER. On the other hand, Northern blots with all
three probes showed that most of NAT6558 was not cleaved
and processed by DICER. Furthermore, hybridization with
LNA6083 indicated that most of the DICER-produced small
RNAs derived from the stem-loop in NAT6531 (Fig. 4C,
middle panel).
Cloning of small RNA generated from NAT6531
To identify the small RNAs derived from NAT6531 through
DICER cleavage, we sequenced the products generated in
vitro by DICER using the NAT as substrate. The sequenced
small RNAs clustered in two distinct regions of the NAT
(Fig. 5A). A ﬁrst sequence (sRNA5, 17 nt in length) corre-
sponded to the stem-loop region identiﬁed by in silico anal-
ysis and Northern blotting with LNA6083. We found also a
longer sequence (sRNA4, 33 nt in length) overlapping
sRNA5 and close to the region considered as the potential
source of sRNAs. Considering the location and abundance
of the two sRNAs, it is likely that sRNA4 and sRNA5 repre-
sent an intermediate cleavage product and the major small
RNA generated by DICER, respectively. Northern blots per-
formed with RNA probes (5930–6113 and 6086–6256)
designed to recognize distinct regions of NAT6531 detected
various small RNA products (Fig. 5B). The two bands
detected by both probes could correspond in size to the
sRNA4 (33-nt) and the shorter sRNA5 (17-nt). The shorter
small RNA product seen only with RNA probe 6086–6256
could correspond to the sRNA6 (15-nt) derived from a sec-
ondary region of processing of NAT6531.
Figure 5. Identiﬁcation of NAT6531 derived small RNAs. (A) Sequences of small RNAs cloned from DICER-processed NAT6531 (left) and their position in the predicted sec-
ondary structure of NAT6531 (right). Nucleotide position of sRNA4 and sRNA5 are reported. Blue and pink dots indicate the boundaries of the RNA probes 5930–6113 and
6086–6256, respectively, used in Northern blots. (B) Northern blot analysis of small RNAs generated in vitro by DICER using NAT6531 as substrate and hybridized with
RNA probe 5930–6113 (left) and RNA probe 6086–6256 (right). Arrows indicate the position of small RNA products.
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Sequence analysis revealed a unique site matching the full
sequence of sRNA5, the main NAT6531-derived DICER prod-
uct, in the human genome and corresponding to the site in the
30distal region of the c-MYC locus. No other sequence with full
length identity or complementarity was found. Despite the
absence of fully complementary sites, we hypothesize that
sRNA5 could act as a miRNA-like molecule interacting with
partial complementarity to the target sequences. To explore
this possibility we use StarMiR39 from the Sfold package to
interrogate the c-MYC locus for potential binding sites of
sRNA5. StarMiR searches for miRNA binding sequences using
CLIP-based predictions.39 Using this approach we found multi-
ple sites (n D 73; 53 sites in promoter/50UTR and 20 sites in
CDS) predicted to be compatible with miRNA-like binding
(Supplementary Table 3). Seventeen sites had the best ﬁt with
canonical miRNA binding features. Best examples are pre-
sented in Supplementary Fig. 6. Interestingly, 14 of the best 17
sites were in the c-MYC promoter and 3 in intron 1. No sites
were found in the 30UTR. Together, these results support the
hypothesis that NAT6531-derived small RNAs could regulate
transcription by acting locally on transcripts generated in the
promoter or in part in the gene body. However, more work is
needed to determine the functionality of the identiﬁed sites and
their impact on c-MYC transcription.
DICER processes NAT6531 and generates endogenous
small RNAs in cells
To determine whether DICER is involved in processing the
endogenous cis-NATs in the c-MYC locus, we knocked down
DICER in PC3 cells using siRNA (Figure Supplementary 6A).
RNA from untreated and SAHA treated cells was examined by
electrophoresis on denaturating polyacrylamide gels followed
by Northern blotting with an RNA probe (probe 5865–6558)
Figure 6. DICER cleavage of 30 distal NATs and production of endogenous small RNA in cells. (A) Northern blot analysis of 30 distal NATs (top panel) and small RNAs (bot-
tom panel) in PC3 cells untreated or treated with SAHA for 6 h after transfection with control (siGL3) or siDICER for 72 h. Gray and black arrows indicate the position of
NATs and small RNAs, respectively. Bottom, schematic representation of the NATs in the c-MYC locus and position of RNA probes used for Northern blotting. (B) c-MYC
mRNA level in PC3 cells transfected for 72 h with in vitro NAT6531-derived small RNA (5 nM) or control siGL3 and then treated with SAHA for additional 6 h. b-actin
mRNA was used as control.
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complementary to a region common to all distal cis-NATs
(Fig. 6A, top panel). Low abundance of the antisense transcripts
makes their detection by Northern blot challenging. Neverthe-
less, probing the long RNA region of the gel we detected tran-
scripts corresponding to the c-MYC cis-NATs in all samples
(Fig. 6A, top panel, and Supplementary Fig. 6B-C). Impor-
tantly, the size of the transcripts increased in SAHA treated
cells compared with control cells, reﬂecting the increase of the
longer more distal NATs expected on the basis of the 50RACE
and RT-PCR. Interestingly, cis-NATs detected in control cells
and cells treated with 2.5 mM SAHA after depletion of DICER
had similar size, indicating that cleavage of the cis-NATs
detected in control cells required DICER and was abolished in
its absence.
To detect small RNAs derived by c-MYC cis-NATs in
cells, we probed the small RNA region of the gel with probe
6060–7086. Small RNAs were detected in untreated PC3
cells matching in size the sRNA4 and sRNA5 produced in
vitro by DICER cleavage of NAT6531 (Fig. 6A, bottom
panel, and Supplementary Fig. 6B). In SAHA treated cells
longer products were detected. Similarly, after DICER
depletion only longer bands were seen both in control and
SAHA treated cells, suggesting that production of the
mature small RNAs was inhibited by both SAHA and
DICER knockdown. These data indicate that DICER is
involved in the cleavage of the full length NAT6531 and
the production of NAT-derived small RNAs in cells.
Our data suggest that the NAT6531-derived small RNAs
could be involved in regulation of c-MYC transcription in
response to HDAC inhibition. To determine whether this
was the case, we puriﬁed the in vitro DICER-produced small
RNAs and transfected them in untreated and SAHA treated
PC3 cells. SAHA (2.5 mM) slightly increased c-MYC mRNA
(Fig. 6B). Transfection of NAT6531-derived small RNAs pre-
vented the increase of c-MYC mRNA in SAHA treated cells,
indicating that the small RNAs had a repressive effect on
c-MYC transcription. These results suggest that the switch
between NAT6531 and NAT6558 induced by local changes
in histone H3 acetylation in the 30 distal region can contrib-
ute to the regulation of transcription of c-MYC by permit-
ting or preventing the synthesis of NAT6531-derived small
RNAs, which might locally control transcription within the
c-MYC locus.
Because DICER is involved in chromatin modiﬁcations
and small RNA processing we also examined how DICER
affected c-MYC mRNA levels in presence or absence of
SAHA. We found that DICER knockdown reduced, although
slightly, c-Myc mRNA in control cells (Supplementary
Fig. 7). In presence of SAHA, c-MYC mRNA was further
reduced by DICER knockdown. Indeed, DICER depletion
abolished the induction of c-MYC expression by low dose of
SAHA and enhanced c-MYC repression at the highest dose.
Although this is apparently in contrast with the effects of
DICER on NAT6531-derived small RNAs, it should be noted
that DICER knockdown increased the level of the 30distal
NAT6558 and specially NAT7281 (Fig. 6A). The longer
NAT has a repressive function and likely overrides any
change in small RNA processing resulting from DICER
depletion. This is particularly evident at the highest dose of
SAHA at which NAT7281 becomes prominent and may in
turn block c-MYC transcription.
Discussion
This study demonstrates the presence of multiple cis-NATs
overlapping the gene and the 30distal region of the c-MYC locus
and highlights the complex relationship between cis-NAT pro-
duction and transcriptional regulation. We show that the pro-
duction of distinct cis-NATs in the c-MYC locus is controlled
epigenetically by the level of histone H3 acetylation in the
30UTR and 30 distal region (Fig. 7). We hypothesize that ﬁne
tuning of the cis-NATs in the 30distal region modulates the
c-MYC transcriptional output in part by controlling the pro-
duction of regulatory small RNAs. c-MYC is a key oncogene
activated in several human cancers.28 Understanding the mech-
anisms controlling c-MYC expression and underlying its dereg-
ulation in cancer may provide insights in the pathogenesis of
human cancer and assist in the development of new therapeutic
strategies.
We show that treatment of cancer cells with HDAC inhibi-
tors, such as SAHA, alters the pattern of cis-NATs in the
c-MYC locus and affects c-MYC transcription. We observed a
complex non-linear relationship between HDAC inhibition,
NAT production and c-MYC expression in terms of dose and
time dependence of the effects. The relationship between gene-
NAT pairs has been shown in many cases to be complex and
dose-dependent. For instance, the clock genes Frequency in
Neurospora and Period in mammals are both associated with
NATs that are tightly regulated to establish repressive hetero-
chromatin through DNA methylation.48 Interestingly, before
the induction of heterochromatin, expression of the NATs cre-
ates a transcriptionally permissive status that promotes sense
transcript expression.48 The response to HDAC inhibition in
terms of transcription of NATs and c-MYC mRNA also is non-
linear. The low dose of SAHA apparently induced a permissive
status that results in transiently increased transcription of
c-MYC mRNA. The high dose of SAHA conversely represses
c-MYC transcription. The effects on the c-MYC transcription
are reﬂected in changes of cis-NATs in the 30distal region of the
gene, suggesting that the antisense transcripts might be impli-
cated in controlling the status of the gene.
c-MYC and other highly expressed genes are known to be
repressed upon HDAC inhibition.25 Gene repression has been
proposed to be due to a block of transcriptional elongation and
not to the activation of indirect repressive factors.25,26 HDACs
have been implicated in transcriptional elongation by limiting
histone acetylation in gene bodies and intergenic regions and
promoting the recruitment of positive elongation factors.26
HDAC inhibitors alter the distribution of acetylated histones
with consequent repositioning of negative elongation factors,
such as NELF.26 However, how these changes in global histone
acetylation are translated locally in activation or repression of
speciﬁc genes is still unclear. Here we show that inhibition of
HDACs results in localized chromatin changes in the 30distal
region of the c-MYC locus and consequent activation of cryptic
initiation sites of antisense transcripts. These ﬁndings, there-
fore, uncover an additional element, cis-NATs, in the complex
mechanisms regulating transcription in response to changes in
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the chromatin status. We found that the production of
cis-NATs in the c-MYC locus depends on the degree of local
histone H3 acetylation whose gradual increase induces different
patterns of antisense transcription. Our data further link
changes in the transcriptional status of the c-MYC gene to the
activation of distinct cis-NATs in the 30 distal region in
response to modulation of HDAC activity. We believe that
these observations highlight an important layer of transcrip-
tional control involving local chromatin modiﬁcations and pro-
duction of cis-NATs, which represent the key elements linking
HDAC activity and transcriptional elongation.
We have investigated the mechanism by which cis-NATs
might inﬂuence c-MYC transcription. Treatment with HDAC
inhibitors shift the balance between NAT6531 and NAT6558.
We hypothesized that the difference in length and sequence
between the two transcripts affects their function. In silico pre-
dictions point to a critical difference in the folding and second-
ary structure of the two NATs. NAT6531is capable of forming
a stem-loop that is missing in NAT6558. As a consequence of
this, NAT6531 acts as an effective substrate of DICER and a
source of small RNAs, which might affect c-MYC transcription.
DICER is known to cleave long double stranded RNAs gen-
erated by transposable elements or convergent transcriptional
units.49 We found that NAT6531 is efﬁciently cleaved by
DICER in vitro. DICER is sufﬁcient to cleave NAT6531 in vitro
and produce small RNAs of discrete sizes using the intramolec-
ular stem-loop and independently of intermolecular double-
stranded RNA. Processing by DICER into small RNAs did not
occur with the highly similar NAT6558, suggesting that the
intramolecular stem-loop dictates the recognition and cleavage
Figure 7. Regulation of transcriptional activity in the c-MYC locus by antisense transcription and histone H3 acetylation. (A) Histone deacetylases (HDACs) prevent activa-
tion of the cryptic initiation sites of the distal NATs. In basal condition NAT6531 is transcribed and processed by DICER to produce small RNAs, which attenuate c-MYC
mRNA transcription likely acting in miRNA-like mode. (B) Mild inhibition of HDACs by low dose of SAHA increases histone H3 acetylation, activates NAT6558 transcription
and block production of NAT6531 and NAT6531-derived small RNAs relieving the block on c-MYC transcription. (C) Strong inhibition of HDACs by high dose of SAHA indu-
ces hyper-acetylation in the 30distal region and activates transcription of the more distal NAT7281 that overrides production of both NAT6531 and NAT6558. In this condi-
tion c-MYC mRNA transcription is strongly repressed.
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of NAT6531. In A. thaliana DICER-like 1 (DCL-1) mediates
processing of stem-loop structures within long noncoding
RNAs as shown by small RNA sequencing and structure analy-
sis.45 Generation of small RNAs by DICER from hairpins
formed at transcription start sites also has been documented in
human cells.50,51 Small RNAs derived from tRNA are produced
by non-canonical DICER activity.52,53 snoRNAs have been
shown to act as non-canonical substrates of DICER in a DRO-
SHA-independent manner.46,47 Sequencing of DICER binding
sites revealed many non-canonical substrates for dicing in
humans and C. elegans.54 In addition, a DICER isoform, whose
expression is driven by a retrotransposon promoter in mouse
oocytes, is able to generate efﬁciently endo-siRNAs.55 This
DICER isoform is able to process intramolecular RNA stems,
in addition to intermolecular double-stranded RNA to produce
small RNAs. Interestingly, this event depends on higher cleav-
age activity of the isoform and substrate availability, indicating
that non-canonical DICER activity may be driven by conditions
enhancing substrate-enzyme interaction.55
In summary, we propose that the transcription of NAT6531
and NAT6558 is regulated by histone H3 acetylation and is
modulated by HDAC activity. The interplay between NAT6531
and NAT6558 changes the ability of DICER to recognize a
stem-loop element in NAT6531 and cleave it to produce small
RNAs. In this context, cis-NATs and NAT-derived small RNAs
act as rheostats to integrate and ﬁne tune the activity of multi-
ple competing inputs in a highly complex regulatory circuit.
The NAT6531-derived small RNAs per se exert a repressive
function on c-MYC mRNA transcription, possibly by modulat-
ing transcription initiation and elongation. The precise mecha-
nism by which the NAT-derived small RNAs exert their
regulatory function has to be further investigated. Sequence
and motif analyses predict that NAT-derived small RNAs may
act as miRNA-like molecules targeting sequences in the c-MYC
promoter and intron 1. cis-NATs and NAT-derived small
RNAs might integrate locally inputs derived from histone mod-
iﬁcations, chromatin binding proteins and RNA processing
activities to modulate the gene transcriptional output. It is
interesting that at higher doses of HDAC inhibitors a longer
antisense transcript, NAT7281, becomes prevalent. The pres-
ence of NAT7281 is associated with strong repression of c-
MYC transcription and shutdown of NAT6531, NAT6558 and
NAT6531-derived small RNAs, suggesting that an additional
more potent repressive mechanism likely overrides the ﬁne
tuning system provided by the interplay between the shorter
cis-NATs. DICER’s role in this process is also complex and
multifaceted. DICER is required for processing of NAT6531
and production of NAT-derived small RNAs. DICER, however,
inﬂuences also the overall level of cis-NATs, including
NAT7281. Therefore, knocking down DICER alters this equi-
librium in favor of the more distal NAT7281 resulting in down-
regulation of c-MYC transcription.
This work focuses on the regulation of c-MYC gene by cis-
NATs and NAT-derived small RNAs. However, these ﬁndings
may have broader implications and open toward new lines of
investigation of interdependent cis-acting long and small non-
coding RNAs that might represent an important and wide-
spread layer of transcriptional tuning and regulation of gene
expression.
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